G8 Countries Generics Market Summary, Competitive Analysis and Forecast to 2027
G8 Countries Generics Market Summary, Competitive Analysis and Forecast to 2027
Summary
The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- G8 countries contributed $149,123.6 million in 2022 to the global generics industry, with a compound annual growth rate (CAGR) of 5.3% between 2018 and 2022. The G8 countries are expected to reach a value of $194,881.1 million in 2027, with a CAGR of 5.5% over the 2022-27 period.
- Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $69,916.7 million in 2022. This was followed by Germany and the UK, with a value of $25,152.7 and $15,416.4 million, respectively.
- The US is expected to lead the generics industry in the G8 nations with a value of $82,184.5 million in 2016, followed by Germany and the UK with expected values of $33,999.8 and $23,214.8 million, respectively.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market
- Leading company profiles reveal details of key generics market players’ G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
- What was the size of the G8 generics market by value in 2022?
- What will be the size of the G8 generics market in 2027?
- What factors are affecting the strength of competition in the G8 generics market?
- How has the market performed over the last five years?
- How large is the G8 generics market in relation to its regional counterparts?
1 INTRODUCTION
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 GROUP OF EIGHT (G8) AIRLINES
2.1. Industry Outlook
3 GENERICS IN CANADA
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 MACROECONOMIC INDICATORS
4.1. Country data
5 GENERICS IN FRANCE
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 MACROECONOMIC INDICATORS
6.1. Country data
7 GENERICS IN GERMANY
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 MACROECONOMIC INDICATORS
8.1. Country data
9 GENERICS IN ITALY
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 MACROECONOMIC INDICATORS
10.1. Country data
11 GENERICS IN JAPAN
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 MACROECONOMIC INDICATORS
12.1. Country data
13 GENERICS IN RUSSIA
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
14 MACROECONOMIC INDICATORS
14.1. Country data
15 GENERICS IN THE UNITED KINGDOM
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
16 MACROECONOMIC INDICATORS
16.1. Country data
17 GENERICS IN THE UNITED STATES
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis
18 MACROECONOMIC INDICATORS
18.1. Country data
19 COMPANY PROFILES
19.1. Novartis AG
19.2. Teva Pharmaceutical Industries Limited
19.3. Viatris Inc.
19.4. Apotex, Inc.
19.5. Pfizer Inc.
19.6. Sanofi SA
19.7. Les Laboratoires Servier
19.8. STADA Arzneimittel AG
19.10. Daiichi Sankyo Co Ltd
19.11. Sawai Pharmaceutical Co Ltd
19.12. Krka, d. d., Novo mesto
19.13. Abbott Laboratories
20 APPENDIX
20.1. Methodology
20.2. About MarketLine
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 GROUP OF EIGHT (G8) AIRLINES
2.1. Industry Outlook
3 GENERICS IN CANADA
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 MACROECONOMIC INDICATORS
4.1. Country data
5 GENERICS IN FRANCE
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 MACROECONOMIC INDICATORS
6.1. Country data
7 GENERICS IN GERMANY
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 MACROECONOMIC INDICATORS
8.1. Country data
9 GENERICS IN ITALY
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 MACROECONOMIC INDICATORS
10.1. Country data
11 GENERICS IN JAPAN
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 MACROECONOMIC INDICATORS
12.1. Country data
13 GENERICS IN RUSSIA
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
14 MACROECONOMIC INDICATORS
14.1. Country data
15 GENERICS IN THE UNITED KINGDOM
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
16 MACROECONOMIC INDICATORS
16.1. Country data
17 GENERICS IN THE UNITED STATES
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis
18 MACROECONOMIC INDICATORS
18.1. Country data
19 COMPANY PROFILES
19.1. Novartis AG
19.2. Teva Pharmaceutical Industries Limited
19.3. Viatris Inc.
19.4. Apotex, Inc.
19.5. Pfizer Inc.
19.6. Sanofi SA
19.7. Les Laboratoires Servier
19.8. STADA Arzneimittel AG
19.10. Daiichi Sankyo Co Ltd
19.11. Sawai Pharmaceutical Co Ltd
19.12. Krka, d. d., Novo mesto
19.13. Abbott Laboratories
20 APPENDIX
20.1. Methodology
20.2. About MarketLine
LIST OF TABLES
Table 1: G8 generics industry, revenue($m), 2018-27
Table 2: G8 generics industry, revenue by country ($m), 2018-22
Table 3: G8 generics industry forecast, revenue by country ($m), 2022-27
Table 4: Canada generics market value: $ million, 2017-22
Table 5: Canada generics market volume: %, 2017-22
Table 6: Canada generics market geography segmentation: $ million, 2022
Table 7: Canada generics market value forecast: $ million, 2022-27
Table 8: Canada generics market volume forecast: %, 2022-27
Table 9: Canada size of population (million), 2018-22
Table 10: Canada gdp (constant 2005 prices, $ billion), 2018-22
Table 11: Canada gdp (current prices, $ billion), 2018-22
Table 12: Canada inflation, 2018-22
Table 13: Canada consumer price index (absolute), 2018-22
Table 14: Canada exchange rate, 2018-22
Table 15: France generics market value: $ million, 2017-22
Table 16: France generics market volume: %, 2017-22
Table 17: France generics market geography segmentation: $ million, 2022
Table 18: France generics market value forecast: $ million, 2022-27
Table 19: France generics market volume forecast: %, 2022-27
Table 20: France size of population (million), 2018-22
Table 21: France gdp (constant 2005 prices, $ billion), 2018-22
Table 22: France gdp (current prices, $ billion), 2018-22
Table 23: France inflation, 2018-22
Table 24: France consumer price index (absolute), 2018-22
Table 25: France exchange rate, 2018-22
Table 26: Germany generics market value: $ million, 2017-22
Table 27: Germany generics market volume: %, 2017-22
Table 28: Germany generics market geography segmentation: $ million, 2022
Table 29: Germany generics market value forecast: $ million, 2022-27
Table 30: Germany generics market volume forecast: %, 2022-27
Table 31: Germany size of population (million), 2018-22
Table 32: Germany gdp (constant 2005 prices, $ billion), 2018-22
Table 33: Germany gdp (current prices, $ billion), 2018-22
Table 34: Germany inflation, 2018-22
Table 35: Germany consumer price index (absolute), 2018-22
Table 36: Germany exchange rate, 2018-22
Table 37: Italy generics market value: $ million, 2017-22
Table 38: Italy generics market volume: %, 2017-22
Table 39: Italy generics market geography segmentation: $ million, 2022
Table 40: Italy generics market value forecast: $ million, 2022-27
Table 41: Italy generics market volume forecast: %, 2022-27
Table 42: Italy size of population (million), 2018-22
Table 43: Italy gdp (constant 2005 prices, $ billion), 2018-22
Table 44: Italy gdp (current prices, $ billion), 2018-22
Table 45: Italy inflation, 2018-22
Table 46: Italy consumer price index (absolute), 2018-22
Table 47: Italy exchange rate, 2018-22
Table 48: Japan generics market value: $ million, 2017-22
Table 49: Japan generics market volume: %, 2017-22
Table 50: Japan generics market geography segmentation: $ million, 2022
Table 51: Japan generics market value forecast: $ million, 2022-27
Table 52: Japan generics market volume forecast: %, 2022-27
Table 53: Japan size of population (million), 2018-22
Table 54: Japan gdp (constant 2005 prices, $ billion), 2018-22
Table 55: Japan gdp (current prices, $ billion), 2018-22
Table 56: Japan inflation, 2018-22
Table 57: Japan consumer price index (absolute), 2018-22
Table 58: Japan exchange rate, 2018-22
Table 59: Russia generics market value: $ million, 2017-22
Table 60: Russia generics market volume: %, 2017-22
Table 61: Russia generics market geography segmentation: $ million, 2022
Table 62: Russia generics market value forecast: $ million, 2022-27
Table 63: Russia generics market volume forecast: %, 2022-27
Table 64: Russia size of population (million), 2018-22
Table 65: Russia gdp (constant 2005 prices, $ billion), 2018-22
Table 66: Russia gdp (current prices, $ billion), 2018-22
Table 67: Russia inflation, 2018-22
Table 68: Russia consumer price index (absolute), 2018-22
Table 69: Russia exchange rate, 2018-22
Table 70: United Kingdom generics market value: $ million, 2017-22
Table 71: United Kingdom generics market volume: %, 2017-22
Table 72: United Kingdom generics market geography segmentation: $ million, 2022
Table 73: United Kingdom generics market value forecast: $ million, 2022-27
Table 74: United Kingdom generics market volume forecast: %, 2022-27
Table 75: United Kingdom size of population (million), 2018-22
Table 76: United Kingdom gdp (constant 2005 prices, $ billion), 2018-22
Table 77: United Kingdom gdp (current prices, $ billion), 2018-22
Table 78: United Kingdom inflation, 2018-22
Table 79: United Kingdom consumer price index (absolute), 2018-22
Table 80: United Kingdom exchange rate, 2018-22
Table 81: United States generics market value: $ million, 2017-22
Table 82: United States generics market volume: %, 2017-22
Table 83: United States generics market geography segmentation: $ million, 2022
Table 84: United States generics market value forecast: $ million, 2022-27
Table 85: United States generics market volume forecast: %, 2022-27
Table 86: United States size of population (million), 2018-22
Table 87: United States gdp (constant 2005 prices, $ billion), 2018-22
Table 88: United States gdp (current prices, $ billion), 2018-22
Table 89: United States inflation, 2018-22
Table 90: United States consumer price index (absolute), 2018-22
Table 91: United States exchange rate, 2018-22
Table 92: Novartis AG: key facts
Table 93: Novartis AG: Annual Financial Ratios
Table 94: Novartis AG: Key Employees
Table 95: Novartis AG: Key Employees Continued
Table 96: Teva Pharmaceutical Industries Limited: key facts
Table 97: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 98: Teva Pharmaceutical Industries Limited: Key Employees
Table 1: G8 generics industry, revenue($m), 2018-27
Table 2: G8 generics industry, revenue by country ($m), 2018-22
Table 3: G8 generics industry forecast, revenue by country ($m), 2022-27
Table 4: Canada generics market value: $ million, 2017-22
Table 5: Canada generics market volume: %, 2017-22
Table 6: Canada generics market geography segmentation: $ million, 2022
Table 7: Canada generics market value forecast: $ million, 2022-27
Table 8: Canada generics market volume forecast: %, 2022-27
Table 9: Canada size of population (million), 2018-22
Table 10: Canada gdp (constant 2005 prices, $ billion), 2018-22
Table 11: Canada gdp (current prices, $ billion), 2018-22
Table 12: Canada inflation, 2018-22
Table 13: Canada consumer price index (absolute), 2018-22
Table 14: Canada exchange rate, 2018-22
Table 15: France generics market value: $ million, 2017-22
Table 16: France generics market volume: %, 2017-22
Table 17: France generics market geography segmentation: $ million, 2022
Table 18: France generics market value forecast: $ million, 2022-27
Table 19: France generics market volume forecast: %, 2022-27
Table 20: France size of population (million), 2018-22
Table 21: France gdp (constant 2005 prices, $ billion), 2018-22
Table 22: France gdp (current prices, $ billion), 2018-22
Table 23: France inflation, 2018-22
Table 24: France consumer price index (absolute), 2018-22
Table 25: France exchange rate, 2018-22
Table 26: Germany generics market value: $ million, 2017-22
Table 27: Germany generics market volume: %, 2017-22
Table 28: Germany generics market geography segmentation: $ million, 2022
Table 29: Germany generics market value forecast: $ million, 2022-27
Table 30: Germany generics market volume forecast: %, 2022-27
Table 31: Germany size of population (million), 2018-22
Table 32: Germany gdp (constant 2005 prices, $ billion), 2018-22
Table 33: Germany gdp (current prices, $ billion), 2018-22
Table 34: Germany inflation, 2018-22
Table 35: Germany consumer price index (absolute), 2018-22
Table 36: Germany exchange rate, 2018-22
Table 37: Italy generics market value: $ million, 2017-22
Table 38: Italy generics market volume: %, 2017-22
Table 39: Italy generics market geography segmentation: $ million, 2022
Table 40: Italy generics market value forecast: $ million, 2022-27
Table 41: Italy generics market volume forecast: %, 2022-27
Table 42: Italy size of population (million), 2018-22
Table 43: Italy gdp (constant 2005 prices, $ billion), 2018-22
Table 44: Italy gdp (current prices, $ billion), 2018-22
Table 45: Italy inflation, 2018-22
Table 46: Italy consumer price index (absolute), 2018-22
Table 47: Italy exchange rate, 2018-22
Table 48: Japan generics market value: $ million, 2017-22
Table 49: Japan generics market volume: %, 2017-22
Table 50: Japan generics market geography segmentation: $ million, 2022
Table 51: Japan generics market value forecast: $ million, 2022-27
Table 52: Japan generics market volume forecast: %, 2022-27
Table 53: Japan size of population (million), 2018-22
Table 54: Japan gdp (constant 2005 prices, $ billion), 2018-22
Table 55: Japan gdp (current prices, $ billion), 2018-22
Table 56: Japan inflation, 2018-22
Table 57: Japan consumer price index (absolute), 2018-22
Table 58: Japan exchange rate, 2018-22
Table 59: Russia generics market value: $ million, 2017-22
Table 60: Russia generics market volume: %, 2017-22
Table 61: Russia generics market geography segmentation: $ million, 2022
Table 62: Russia generics market value forecast: $ million, 2022-27
Table 63: Russia generics market volume forecast: %, 2022-27
Table 64: Russia size of population (million), 2018-22
Table 65: Russia gdp (constant 2005 prices, $ billion), 2018-22
Table 66: Russia gdp (current prices, $ billion), 2018-22
Table 67: Russia inflation, 2018-22
Table 68: Russia consumer price index (absolute), 2018-22
Table 69: Russia exchange rate, 2018-22
Table 70: United Kingdom generics market value: $ million, 2017-22
Table 71: United Kingdom generics market volume: %, 2017-22
Table 72: United Kingdom generics market geography segmentation: $ million, 2022
Table 73: United Kingdom generics market value forecast: $ million, 2022-27
Table 74: United Kingdom generics market volume forecast: %, 2022-27
Table 75: United Kingdom size of population (million), 2018-22
Table 76: United Kingdom gdp (constant 2005 prices, $ billion), 2018-22
Table 77: United Kingdom gdp (current prices, $ billion), 2018-22
Table 78: United Kingdom inflation, 2018-22
Table 79: United Kingdom consumer price index (absolute), 2018-22
Table 80: United Kingdom exchange rate, 2018-22
Table 81: United States generics market value: $ million, 2017-22
Table 82: United States generics market volume: %, 2017-22
Table 83: United States generics market geography segmentation: $ million, 2022
Table 84: United States generics market value forecast: $ million, 2022-27
Table 85: United States generics market volume forecast: %, 2022-27
Table 86: United States size of population (million), 2018-22
Table 87: United States gdp (constant 2005 prices, $ billion), 2018-22
Table 88: United States gdp (current prices, $ billion), 2018-22
Table 89: United States inflation, 2018-22
Table 90: United States consumer price index (absolute), 2018-22
Table 91: United States exchange rate, 2018-22
Table 92: Novartis AG: key facts
Table 93: Novartis AG: Annual Financial Ratios
Table 94: Novartis AG: Key Employees
Table 95: Novartis AG: Key Employees Continued
Table 96: Teva Pharmaceutical Industries Limited: key facts
Table 97: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 98: Teva Pharmaceutical Industries Limited: Key Employees
